Class 4 MHRA Drug Alert – Zoledronic acid 5mg solution for infusion (Sun Pharmaceutical Industries Europe BV)

Class 4 MHRA Drug Alert – Zoledronic acid 5mg solution for infusion (Sun Pharmaceutical Industries Europe BV)

April 4, 2019

Drug Alert No: El (19) A/08
Date Issued: 4th April 2019

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 drug alert for Zoledronic acid 5mg solution for infusion (Sun Pharmaceutical Industries Europe BV)

Zoledronic acid 5mg solution for infusion ( Sun Pharmaceutical Industries Europe BV) PL 31750/0054

Batch Number Expiry Date Pack Size First Distributed
JKT1576A 30/04/2020 1 x 100ml 12th October 2018

Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, have informed MHRA, that some packs from the above batch contain a Patient Information Leaflet (PIL) for Temozolomide 180mg capsules.

Community pharmacy teams should check the PIL, and if the pack contains the wrong PIL, this should be removed and a copy of the correct PIL provided. This can be downloaded here.

View the full alert here

For any enquiries, please contact Ranbaxy / Sun Pharmaceuticals Customer Services Team on 020 8848 5050 or email Cserv.uk@sunpharma.com

 

 



Posted in:


More Latest News >

Ask PSNC: Flu FAQs

The team at PSNC has received a number of queries on the NHS Flu Vaccination Service 2019/20. Below are some...